| Summary: | <p style="margin-bottom: 0in;"><span style="color: #231f20;"><span style="font-family: Arial,sans-serif;"><span style="font-size: x-small;">Subclinical thyroid disease is commonly encountered now as more patients with vague, non-specific symptoms are being evaluated with ultra-sensitive, third generation TSH assays. The clinical significance of mild thyroid over-activity and under-activity is uncertain, which has led to controversy over the appropriateness of diagnostic testing and possible treatment. In this article, we discuss the definition, differential diagnoses, risks of progression, potential health outcomes and management of subclinical thyroid dysfunction.</span></span></span></p> <p style="margin-bottom: 0in;"><span style="color: #231f20;"><span style="font-family: Arial,sans-serif;"><span style="font-size: x-small;">DOI: <a href="http://dx.doi.org/10.4038/sjdem.v3i2.6367">http://dx.doi.org/10.4038/sjdem.v3i2.6367</a></span></span></span></p><p style="margin-bottom: 0in;"><span style="color: #231f20;"><span style="font-family: Times New Roman,serif;"><span style="font-size: x-small;"><em>Sri Lanka Journal of Diabetes, Endocrinology and Metabolism </em>2013; <strong>3</strong>: 84-87</span></span></span></p>
|
|---|